We found a high rate (4.2%) of positive results for lysergic acid diet
hylamide (LSD) by Emit in 1898 urine samples that were submitted prima
rily from psychiatric patients for drugs-of-abuse (DOA) testing. Speci
mens that tested positive for LSD by Emit subsequently tested negative
for LSD with two RIAs. Furthermore, LSD was not detected in randomly
selected Emit-positive urine samples by gas chromatography-mass spectr
ometry. Normal urine samples tested positive for LSD by Emit when they
were supplemented with therapeutic medications that were prescribed f
or patients with positive urine LSD results by Emit. These therapeutic
drugs interfered specifically with the Emit assay for LSD, since othe
r Emit DOA tests were not affected by these medications at the tested
concentrations.